- Antiangiogenesis therapy: an update after the first decade
-
De Falco S
- KMID: 1792005
- Korean J Intern Med.
- 2014 Jan;29(1):1-11.
- doi: 10.3904/kjim.2014.29.1.1
Angiogenesis is a complex biological phenomenon that forms new blood vessels from the pre-existing vasculature. Aberrant angiogenesis has been implicated in a variety of diseases such as cancer, atherosclerosis, arthritis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1
-
Kang JH, Kim SA, Chang SY, Hong S, Hong KJ
- KMID: 1047092
- Exp Mol Med.
- 2007 Jun;39(3):402-411.
Expression of thrombospondin-1 (TSP-1), which is a known inhibitor of tumor growth and angiogenesis, is reciprocally regulated by positive regulators, such as VEGF. Additionally, trichostatin A (TSA) suppresses tumor progression... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Angiostatin, Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9 and 12 in the Angiogenesis of Hepatocellular Carcinoma
-
Kim S, Park HS, Son HJ, Moon WS
- KMID: 760532
- Korean J Hepatol.
- 2004 Mar;10(1):62-72.
BACKGROUND/AIMS: Tumor angiogenesis, a major requirement for tumor growth and metastasis, is regulated by pro- and anti-angiogenic factors. Hepatocellular carcinoma (HCC) has become a common malignant tumor worldwide. It... -
- CITED
-
- Close
- SHARE
-
- Close
